Search Results - "Matzner, U"
-
1
Bone marrow stem cell-based gene transfer in a mouse model for metachromatic leukodystrophy: effects on visceral and nervous system disease manifestations
Published in Gene therapy (2002)“…Arylsulfatase A (ASA) knockout mice represent an animal model for the lysosomal storage disease metachromatic leukodystrophy (MLD). Stem cell gene therapy with…”
Get full text
Journal Article -
2
Bone marrow stem cell-based gene transfer in a mouse model for metachromatic leukodystrophy: effects on visceral and nervous system disease manifestations
Published in Gene therapy (01-01-2002)“…Arylsulfatase A (ASA) knockout mice represent an animal model for the lysosomal storage disease metachromatic leukodystrophy (MLD). Stem cell gene therapy with…”
Get full text
Journal Article -
3
Retrovirally expressed human arylsulfatase A corrects the metabolic defect of arylsulfatase A-deficient mouse cells
Published in Gene therapy (01-05-2000)“…A deficiency of arylsulfatase A (ASA) causes the lysosomal storage disease metachromatic leukodystrophy (MLD) which is characterized primarily by demyelination…”
Get full text
Journal Article -
4
Long-term expression and transfer of arylsulfatase A into brain of arylsulfatase A-deficient mice transplanted with bone marrow expressing the arylsulfatase A cDNA from a retroviral vector
Published in Gene therapy (01-07-2000)“…A deficiency of arylsulfatase A (ASA) results in the lysosomal lipid storage disease metachromatic leukodystrophy. The disease mainly affects the central…”
Get full text
Journal Article -
5
Lysosomal sulfoglycolipid storage in the kidneys of mice deficient for arylsulfatase A (ASA) and of double-knockout mice deficient for ASA and galactosylceramide synthase
Published in Histochemistry and cell biology (01-08-2001)“…The inherited deficiency of arylsulfatase A (ASA) causes lysosomal accumulation of sulfoglycolipids (mainly sulfo-galactosylceramide, S-GalCer ) and leads to…”
Get full text
Journal Article -
6
Metachromatic leukodystrophy: Molecular genetics and an animal model
Published in Journal of inherited metabolic disease (01-08-1998)“…Metachromatic leukodystrophy (MLD) is a lysosomal storage disorder caused by the deficiency of arylsulphatase A (ASA; EC 3.1.6.8). Deficiency of this enzyme…”
Get full text
Journal Article Conference Proceeding -
7
Modest phenotypic improvements in ASA-deficient mice with only one UDP-galactose:ceramide-galactosyltransferase gene
Published in Lipids in health and disease (07-08-2006)“…Arylsulfatase A (ASA)-deficient mice are a model for the lysosomal storage disorder metachromatic leukodystrophy. This lipidosis is characterised by the…”
Get full text
Journal Article -
8
Bone marrow stem cell gene therapy of arylsulfatase A-deficient mice, using an arylsulfatase A mutant that is hypersecreted from retrovirally transduced donor-type cells
Published in Human gene therapy (10-06-2001)“…Arylsulfatase A (ASA)-deficient mice represent an animal model for the fatal lysosomal storage disease metachromatic leukodystrophy, which is characterized by…”
Get more information
Journal Article -
9
Expression of the two mannose 6-phosphate receptors is spatially and temporally different during mouse embryogenesis
Published in Development (Cambridge) (01-04-1992)“…Mammalian cells express two mannose 6-phosphate receptors, MPR46 and MPR300, both of which mediate the targeting of lysosomal enzymes to lysosomes…”
Get full text
Journal Article -
10
Targeted disruption of the M(r) 46,000 mannose 6‐phosphate receptor gene in mice results in misrouting of lysosomal proteins
Published in The EMBO journal (15-12-1993)“…Lysosomal enzymes containing mannose 6‐phosphate recognition markers are sorted to lysosomes by mannose 6‐phosphate receptors (MPRs). The physiological…”
Get full text
Journal Article -
11
Intracerebroventricular enzyme infusion corrects central nervous system pathology and dysfunction in a mouse model of metachromatic leukodystrophy
Published in Human molecular genetics (15-07-2011)“…Arylsulfatase A (ASA) catalyzes the desulfation of sulfatide, a major lipid component of myelin. Inherited functional deficiencies of ASA cause the lysosomal…”
Get full text
Journal Article -
12
Efficacy of enzyme replacement therapy in an aggravated mouse model of metachromatic leukodystrophy declines with age
Published in Human molecular genetics (01-06-2012)“…Metachromatic leukodystrophy (MLD) is a lysosomal storage disease caused by a functional deficiency of arylsulfatase A (ASA). Previous studies in ASA-knockout…”
Get full text
Journal Article -
13
Translational control of arylsulfatase A expression in mouse testis
Published in The Journal of biological chemistry (16-09-1994)“…Arylsulfatase A is a lysosomal enzyme that is involved in the degradation of sulfated glycolipids. High levels of arylsulfatase A mRNA are found in germ cells…”
Get full text
Journal Article -
14
Enzyme replacement improves nervous system pathology and function in a mouse model for metachromatic leukodystrophy
Published in Human molecular genetics (01-05-2005)“…A deficiency of arylsulfatase A (ASA) causes the lysosomal storage disease metachromatic leukodystrophy, which is characterized by accumulation of the…”
Get full text
Journal Article -
15
Gene therapy of metachromatic leukodystrophy
Published in Expert opinion on biological therapy (01-01-2005)“…Metachromatic leukodystrophy (MLD) is a lysosomal storage disease that is caused by a deficiency of arylsulfatase A (ASA). The deficiency results in the…”
Get more information
Journal Article -
16
Secretion of phosphomannosyl-deficient arylsulphatase A and cathepsin D from isolated human macrophages
Published in Biochemical journal (15-12-2002)“…The transfer of macrophage-secreted arylsulphatase A (ASA) to enzyme-deficient brain cells is part of the therapeutic concept of bone marrow transplantation in…”
Get full text
Journal Article -
17
Gene therapy: prospects for glycolipid storage diseases
Published in Philosophical transactions of the Royal Society of London. Series B. Biological sciences (29-05-2003)“…gene therapy. We review the rationale for gene therapy in lysosomal disorders and present data, in particular, about trials in an animal model of metachromatic…”
Get full text
Journal Article -
18
Quantitative genotyping of single-nucleotide polymorphisms by allele-specific oligonucleotide hybridization on DNA microarrays
Published in Biotechnology and applied biochemistry (01-08-2005)“…Genotyping of SNPs (single‐nucleotide polymorphisms) has challenged the development of several novel techniques [Twyman and Primrose (2003) Pharmacogenomics 4,…”
Get full text
Journal Article -
19
Targeted disruption of the Mr 46 000 mannose 6-phosphate receptor gene in mice results in misrouting of lysosomal proteins
Published in The EMBO journal (1993)Get full text
Journal Article -
20
Expression of mannose 6‐phosphate receptors in chicken
Published in Developmental dynamics (01-09-1996)“…In mammals, the sorting of newly synthesized lysosomal enzymes is accomplished by two mannose 6‐phosphate receptors (MPR) designated MPR46 and MPR300. MPR300…”
Get full text
Journal Article